Welcome to our dedicated page for FRACTAL news (Ticker: FRACTAL), a resource for investors and traders seeking the latest updates and insights on FRACTAL stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FRACTAL's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FRACTAL's position in the market.
Fractal (NSE:FRACTAL) reported Q3 FY2026 consolidated revenue of INR 8,544 m, up 21% YoY, with Adjusted EBITDA INR 1,521 m (+24% YoY) and Profit after Tax of INR 1,001 m for quarter ended Dec 31, 2025.
Gross margin improved to 47.2%; Healthcare & Life Sciences grew 78% YoY and Banking grew 26% YoY. Net Revenue Retention was 114% and NPS was 77. Product benchmarks included Vaidya.ai 2.0 and PiEvolve outperforming peer models on public AI tests.